American College of Medical Genetics (1995). Folic acid and pregnancy. Am. Coll. Med. Genet. Newsl. 4: 9.
Ashton, J. R. (1980). The psychosocial outcomes of induced abortion. Br. J. Obstet. Gynecol. 87: 1115–1122.
Bandura, A. (1986). Social Foundations of Thought and Action: A Social Cognitive Theory, Englewoods Cliffs, NJ: Prentice Hall.
Baum, A., Friedman, A. L., and Zakowski, S. G. (1997). Stress and genetic testing for disease risk. Health Psychol. 16: 8–19.
Botto, L. D., Moore, C. A., Khoury, M. J., and Erickson, J. D. (1999). Neural-tube defects. New Engl. J. Med. 341: 1509–1519.
Burton, B. K., Dillard, R. G., and Clark, E. N. (1985a). The psychological impact of false positive elevations of maternal serum alpha-fetoprotein. Am. J. Obstet. Gynecol. 151: 77–82.
Burton, B. K., Dillard, R. G., and Clark, E. N. (1985b). Maternal serum alpha-fetoprotein screening: The effect of participation on anxiety and attitude toward pregnancy in women with normal results. Am. J. Obstet. Gynecol. 152: 540–543.
Carver, C. S., and Gaines, J. G. (1987). Optimism, pessimism, and postpartum depression. Cogn. Ther. Res. 11: 449–462.
Carver, C. S., Pozo, C., Harris, S. D., Noriega, V., Scheier, M. F., Robinson, D. S., Ketcham, A. S., Moffat, Jr., F. L., Clark, K. C. (1993). How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer. J. Pers. Soc. Psychol. 65: 375–390.
Centers for Disease Control and Prevention (1994). Down syndrome prevalence at birth—United States, 1990. Morb. Mortal. Week. Rep. 43: 617–622.
Coley, R. L., and Chase-Lansdale, P. L. (1998). Adolescent pregnancy and parenthood: Recent evidence and future directions. Am. Psychol. 53: 152–166.
Croyle, R. T., and Lerman, C. (1995). Psychological impact of genetic testing. In Croyle, R. T. (Ed.), Psychosocial Effects of Screening for Disease Prevention and Detection, Oxford University Press, NY, pp. 11–38.
Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., and Nash, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol. 16: 63–72.
Cuckle, H. S., Wald, N. J., and Lindenbaum, R. H. (1984). Maternal serum alpha-fetoprotein measurement: A screening test for Down syndrome. Lancet 1: 926–929.
Dias, L., and Lobel, M. (1997). Social comparison in medically high-risk pregnant women. J. Appl. Soc. Psychol. 27: 1629–1649.
Dixson, B., Richards, T. L., Reinsch, R. N., Edrich, B. S., Matson, M. R., and Jones, O. W. (1981). Mid-trimester amniocentesis: Subjective maternal responses. J. Repro. Med. 26: 10–16.
Dunkel-Schetter, C., Gurung, R. A. R., Lobel, M., and Wadhwa, P. D. (2001). Stress processes in pregnancy and birth: Psychological, biological, and sociocultural influences. In Baum, A., Revenson, T. A., and Singer, J. E. (Eds.), Handbook of Health Psychology, Erlbaum, Hillsdale, NJ, pp. 495–518.
Evers-Kiebooms, G., Swerts, A., and Van den Berghe, H. (1988). Psychological aspects of amniocentesis: Anxiety feelings in three different risk groups. Clin. Genet. 33: 196–206.
Faden, R. R., Chwalow, J., Orel-Crosby, E., Holtzman, N. A., Chase, G. A., Leonard, C. O. (1985). What participants understand about a maternal serum alpha-fetoprotein screening program. Am. J. Pub. Health 75: 1381–1384.
Faden, R. R., Chwalow, A. J., Quaid, K., Chase, G. A., Lopes, C., Leonard, C. O., and Holtzman, N. A. (1987). Prenatal screening and pregnant women’s attitudes toward the abortion of defective fetuses. Am. J. Pub. Health 77: 288–290.
Fearn, J., Hibbard, B. M., Laurence, K. M., Roberts, A., and Robinson, J. O. (1982). Screening for neural-tube defects and maternal anxiety. Br. J. Obstet. Gynaecol. 89: 218–221.
Festinger, L. (1957). A theory of Cognitive Dissonance, Stanford University Press, Stanford, CA.
Finley, S. C., Varner, P. D., Vinson, P. C., and Finley, W. H. (1977). Participants’ reaction to amniocentesis and prenatal genetic studies. J. Am. Med. Assoc. 238: 2377–2381.
Freda, M. C., DeVore, N., Valentine-Adams, N., Bombard, A., and Merkatz, I. R. (1998). Informed consent for maternal serum alpha-fetoportein screening in an inner city population: How informed is it? J. Obstet. Gynecol. Neonat. Nurs. 27: 99–106.
Gates, E. A. (1994). Prenatal genetic testing: Does it benefit pregnant women? In Rothenberg, K. H. and Thomson, E. J. (Eds.), Women and Prenatal Testing: Facing the Challenges of Genetic Technology, Ohio State University Press, Columbus, pp. 183–200.
Harris, R. (1980). Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect. BMJ 1199–1202.
Honein, M. A., Paulozzi, L. J., Mathews, T. J., Erickson, J. D., and Wong, L. C. (2001). Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J. Am. Med. Assoc. 285: 2981–2986.
Kahneman, D., and Tversky, A. (1984). Choices, values, & frames. Am. Psychol. 39: 341–350.
Kessler, S., and Levine, E. K. (1987). Psychological aspects of genetic counseling. IV. The subjective assessment of probability. Am. J. Med. Genet. 28: 361–370.
Kidd, J., Cook, R., and Marteau, T. M. (1993). Is routine AFP screening in pregnancy reassuring? J. Psychosom. Res. 37: 717–722.
Laurence, K. M., and Morris, J. (1981). The effect of the introduction of prenatal diagnosis on the reproductive history of women at increased risk from neural tube defects. Prenat. Diagn. 1: 51–60.
Lauver, D., and Tak, Y. (1995). Optimism and coping with a breast cancer symptom. Nurs. Res. 44: 202–207.
Lazarus, R. S., and Folkman, S. (1984). Stress, Appraisal, and Coping, Springer Publishing Company, New York.
Lazarus, R. S., and Launier, R. (1978). Stress-related transactions between person and environment. In L. A. Pervin and M. Lewis (Eds.), Perspectives in interactional psychology, Plenum, New York, pp. 287–327.
Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., and Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol. 10: 259–267.
Lobel, M. (1994). Conceptualizations, measurement, and effects of prenatal maternal stress on birth outcomes. J. Behav. Med. 17: 225–272.
Lobel, M. (1998). Mental health in pregnancy. In Friedman, H. (Ed.), The Encyclopedia of Mental Health, Academic Press, San Diego, CA, pp. 229–238.
Lobel, M., DeVincent, C. J., Kaminer, A., and Meyer, B. A. (2000). The impact of prenatal maternal stress and optimistic disposition on birth outcomes in medically high risk women. Health Psychol. 19: 544–553.
Lobel, M., and Dunkel-Schetter, C. (1990). Conceptualizing stress to study effects on health: Environmental, perceptual, and emotional components. Anx. Res. 3: 213–230.
Lobel, M., Dunkel-Schetter, C., and Scrimshaw, S. C. M. (1992). Prenatal maternal stress and prematurity: A prospective study of socioeconomically disadvantaged women. Health Psychol. 11: 32–40.
Lobel, M., Yali, A. M., Zhu, W., DeVincent, C. J., and Meyer, B. A. (2002). Beneficial associations between optimistic disposition and emotional distress in high-risk pregnancy. Psychol. Health 17: 77–95.
Macri, J. N., and Weiss, R. R. (1982). Prenatal serum alpha-fetoprotein screening for neural tube defects. Obstet. Gynecol. 59: 633.
Marteau, T. M. (1993). Health-related screening: Psychological predictors of uptake and impact. In Maes, S., Leventhal, H., and Johnston, M. (Eds.), International Review of Health Psychology, Vol. 2, Wiley, Chichester, England, pp. 150–174.
Marteau, T. M., Cook, R., Kidd, J., Michie, S., Johnston, M., Slack, J., and Shaw, R. W. (1992a). The psychological effects of false-positive results in prenatal screening for fetal abnormality: A prospective study. Prenat. Diagn. 12: 205–215.
Marteau, T. M., Johnston, M., Plenicar, M., Shaw, R. W., and Slack, J. (1988). Development of a self-administered questionnaire to measure women’s knowledge of prenatal screening and diagnostic tests. J. Psychosom. Res. 32: 403–408.
Marteau, T. M., Johnston, M., Shaw, R. W., and Slack, J. (1989). Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down’s syndrome. Br. J. Obstet. Gynecol. 96: 739–748.
Marteau, T. M., Slack, J., Kidd, J., and Shaw, W. (1992b). Presenting a routine screening test in antenatal care: Practice observed. Pub. Health 106: 131–141.
Meaney, J. F., Riggle, S. M., and Cunningham, G. C. (1993). Providers and consumers of prenatal genetic services: What do the data tell us? Fetal Diagn. Ther. 8(Suppl. 1): 18–27.
Merkatz, I. R., Nitowsky, H. M., Macri, J. N., and Johnson, W. E. (1984). An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol. 148: 886–894.
MRC Vitamin Study Research Group (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338: 131.
National Center for Health Statistics (2001). Healthy People 2000 Final Review, Public Health Service, Hyattsville, MD.
Olson, J. M., and Ross, M. (1985). Attribution research: Past contributions, current trends, and future prospects. In Harvey, J. H., and Weary, G. (Eds.), Attribution: Basic Issues and Applications, Academic Press, NY.
Press, N. A., and Browner, C. H. (1994). Collective silences, collective fictions: How prenatal diagnostic testing became a part of routine prenatal care. In Rothenberg, K. H., and Thomson, E. J. (Eds.), Women and Prenatal Testing: Facing the Challenges of Genetic Technology, Ohio State University Press, Columbus, pp. 201–218.
Press, N., and Browner, C. H. (1998). Characteristics of women who refuse an offer of prenatal diagnosis: Data from the California maternal serum alpha fetoprotein blood test experience. Am. J. Med. Genet. 78: 433–445.
Ralston, G. E., and Rothwell, B. (1992). Knowledge of AIDS and HIV among various groups. Br. J. Addict. 87: 1663–1668.
Robinson, A., and Henry, G. P. (1985). Prenatal diagnosis by amniocentesis. Ann. Rev. Med. 36: 13–26.
Robinson, J. O., Hibbard, B. M., and Laurence, K. M. (1984). Anxiety during a crisis: Emotional effects of screening for neural tube defects. J. Psychosom. Res. 28: 163–169.
Ross, H. L., and Elias, S. (1997). Maternal serum screening for fetal genetic disorders. Obstet. Gynecol. Clin. North Am. 24: 33–47.
Scheier, M. F., and Carver, C. S. (1985). Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. Health Psychol. 4: 219–247.
Scheier, M. F., Matthews, K. A., Owens, J. F., Magovern, G. J., Sr., Lefebvre, R. C., Abbott, R. A., and Carver, C. S. (1989). Dispositional optimism and recovery from coronary artery bypass surgery: The beneficial effects on physical and psychological well-being. J. Pers. Soc. Psychol. 57: 1024–1040.
Shiloh, S., and Sagi, M. (1989). Effect of framing on the perception of genetic recurrence risks. Am. J. Med. Genet. 33: 130–135.
Sjogren, B., and Uddenberg, N. (1988). Decision making during the prenatal diagnostic procedure: A questionnaire and interview study of 211 women participating in prenatal diagnosis. Prenat. Diagn. 8: 263–273.
Spielberger, C. D. (1995). Preliminary Manual for the State-Trait Personality Inventory (STPI), Center for Research in Behavioral Medicine and Health Psychology, University of South Florida, Tampa.
Stanton, A. L., Lobel, M., Sears, S., and DeLuca, R. S. (2002). Psychosocial aspects of selected issues in women’s reproductive health: Current status and future directions. J. Consult. Clin. Psychol. 70: 751–770.
Stanton, A. L., and Snider, P. R. (1993). Coping with a breast cancer diagnosis: A prospective study. Health Psychol. 12: 16–23.
Taylor, S. E., and Clark, L. F. (1985). Does information improve adjustment to noxious medical procedures? In Kidd, R. F., and Saks, M. J. (Eds.), Advances in Applied Social Psychology, Erlbaum, Hillsdale, NJ, pp. 1–28.
Taylor, S. E., Kemeny, M. E., Aspinwall, L. G., Schneider, S. G., Rodriguez, R., and Herbert, M. (1992). Optimism, coping, psychological distress, and high-risk sexual behavior among men at risk for Acquired Immunodeficiency Syndrome (AIDS). J. Pers. Soc. Psychol. 63: 460–473.
Tymstra, T. (1989). The imperative character of medical technology and the meaning of “anticipated decision regret.” Int. J. Technol. Assess. Health Care 5: 207–213.
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., Wilson, R. D., Mohide, P., Hershey, D., Krantz, D., Zachary, J., Snijders, R., Greene, N., Sabbagha, R., MacGregor, S., Hill, L., Gagnon, A., Hallahan, T., and Jackson, L. (2003). First-trimester screening for trisomies 21 and 18. New Engl. J. Med. 349: 1405–1413.
Yali, A. M., and Lobel, M. (1999). Coping and distress in pregnancy: An investigation of medically high risk women. J. Psychosom. Obstet. Gynecol. 20: 39–52.
Zuskar, D. M. (1987). The psychological impact of prenatal diagnosis of fetal abnormality: Strategies for investigation and intervention. Women Health 12: 91–103.